Group 1 - Shandong Heda's stock increased by 5.07% to 20.10 CNY per share, with a trading volume of 234 million CNY and a turnover rate of 3.66%, resulting in a total market capitalization of 7.012 billion CNY [1] - The company, established on December 7, 1992, and listed on August 26, 2016, specializes in the research, production, and sales of water-soluble polymer compounds and downstream chemical products [1] - The revenue composition of Shandong Heda includes 72.98% from self-produced cellulose ether products, 21.10% from plant hollow capsules, 3.86% from other chemical products, 1.90% from graphite products, and 0.16% from other sources [1] Group 2 - E Fund's health-themed mixed fund (001898) holds 1.2881 million shares of Shandong Heda, accounting for 4.86% of the fund's net value, making it the eighth largest holding [2] - The fund has generated a floating profit of approximately 1.2495 million CNY today [2] - E Fund's health-themed mixed fund was established on September 27, 2017, with a current size of 393 million CNY, yielding 5.46% year-to-date and 29.73% over the past year [2] Group 3 - The fund manager of E Fund's health-themed mixed fund is Xu Zheng, who has been in the position for 2 years and 356 days [3] - The total asset size of the fund is 3.364 billion CNY, with the best return during Xu Zheng's tenure being 23.07% and the worst being 0.69% [3]

Core Viewpoint - Shandong Heda (SZ002810) experienced a trading limit increase of 10%, reaching a price of 18.59 yuan, driven by significant reductions in anti-dumping duties in the U.S. and expansion into high-value-added sectors [2] Group 1: Company Developments - The company's subsidiary saw a drastic reduction in the U.S. anti-dumping tax rate from 172.24% to 18.71%, enhancing its competitiveness in the U.S. market and potentially increasing market share and profits [2] - Shandong Heda is expanding its business into high-value-added areas such as bio-based materials and pharmaceutical excipients, which could improve its valuation and lay a foundation for long-term growth [2] - The company anticipates a 55.2% year-on-year growth in related transactions for 2026, indicating strong business expansion potential [2] Group 2: Market and Technical Analysis - The chemical industry has seen active performance due to favorable policies and market demand, with Shandong Heda benefiting from this sector-wide momentum [2] - Technical indicators, such as the MACD forming a golden cross and the stock price breaking through key resistance levels, may attract technical investors, contributing to the stock's price increase [2] - Significant net inflows from large orders on the day indicate that major funds are optimistic about the company's future prospects [2]

Group 1 - The core viewpoint of the news is that Shandong Heda's financial performance shows mixed results, with a slight increase in revenue but a significant decrease in net profit [2][3] - As of January 6, Shandong Heda's financing balance reached 187 million yuan, accounting for 3.71% of its market capitalization, indicating a high level of financing activity [1] - The company reported a revenue of 1.437 billion yuan for the first nine months of 2025, reflecting a year-on-year growth of 0.11%, while the net profit attributable to shareholders decreased by 29.65% to 139 million yuan [2] Group 2 - Shandong Heda has distributed a total of 411 million yuan in dividends since its A-share listing, with 258 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders decreased by 1.52% to 26,000, while the average circulating shares per person increased by 1.55% to 12,284 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited increased its holdings by 770,300 shares to 3.6568 million shares, while Huashang Zhenxuan Return Mixed A reduced its holdings by 42,700 shares to 2.0926 million shares [3]